Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells

European Journal of Cancer

Volumn 50, Issue 16, 2014, Pages 2877-2886

  Fan, Ping ^a   Cunliffe, Heather E ^b,e   Griffith, Obi L ^c   Agboke, Fadeke A ^a   Ramos, Pilar ^b   Gray, Joe W ^d   Jordan, V Craig ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d Oregon Health and Science University Department of Biomedical Engineering   (United States)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Gene expression profiling; Membrane associated molecules; Oestrogen; Tamoxifen

Indexed keywords

AFIMOXIFENE; EH DOMAIN CONTAINING 2 PROTEIN; ESTRADIOL; ESTROGEN RECEPTOR; FOUR AND A HALF LIM DOMAIN 2 PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN HOMER 3; RAS HOMOLOGUE FAMILY MEMBER F PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL GROWTH; CELL ORGANELLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; OVERLAPPING GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION; WILD TYPE; ANALOGS AND DERIVATIVES; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; DNA MICROARRAY; DRUG EFFECTS; FEMALE; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; CELL PROLIFERATION; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEQUENCE ANALYSIS, RNA; TAMOXIFEN;

EID: 84923595802     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.08.010     Document Type: Article

References (43)

1. V.C. Jordan, and A.M. Brodie Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer Steroids 72 2007 7 25
2. D.M. Wolf, and V.C. Jordan A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapy Recent Results Cancer Res 127 1993 23 33
3. K. Yao, E.S. Lee, and D.J. Bentrem Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice Clin Cancer Res 6 2000 2028 2036
4. J.S. Lewis-Wambi, and V.C. Jordan Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res 11 2009 206
5. J.S. Lewis, K. Meeke, and C. Osipo Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation J Natl Cancer Inst 97 2005 1746 1759
6. R.X. Song, G. Mor, and F. Naftolin Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol J Natl Cancer Inst 93 2001 1714 1723
7. M.J. Ellis, F. Gao, and F. Dehdashti Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study JAMA 302 2009 774 780
8. G.L. Anderson, R.T. Chlebowski, and A.K. Aragaki Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial Lancet Oncol 13 2012 476 486
9. S. Hiscox, P. Barrett-Lee, A.C. Borley, and R.I. Nicholson Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone loss Eur J Cancer 46 2010 2187 2195
10. P. Fan, J. Wang, R.J. Santen, and W. Yue Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells Cancer Res 67 2007 1352 1360
11. P. Fan, R.E. McDaniel, H.R. Kim, D. Clagett, B. Haddad, and V.C. Jordan Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines Eur J Cancer 48 2012 3488 3498
12. P. Fan, O.L. Griffith, and F.A. Agboke c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells Cancer Res 73 2013 4510 4520
13. E.A. Ariazi, H.E. Cunliffe, and J.S. Lewis-Wambi Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time Proc Natl Acad Sci USA 108 2011 18879 18886
14. E.E. Sweeney, P. Fan, and V.C. Jordan Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells Int J Oncol 44 2014 1529 1538
15. P. Fan, F.A. Agboke, and R.E. McDaniel Inhibition of c-Src blocks oestrogen-induced apoptosis and restores oestrogen-stimulated growth in long-term oestrogen-deprived breast cancer cells Eur J Cancer 50 2014 457 468
16. M. Griffith, O.L. Griffith, and J. Mwenifumbo Alternative expression analysis by RNA sequencing Nat Methods 7 2010 843 847
17. O. Daumke, R. Lundmark, Y. Vallis, S. Martens, P.J. Butler, and H.T. McMahon Architectural and mechanistic insights into an EHD ATPase involved in membrane remodelling Nature 449 2007 923 927
18. M.J. McGrath, L.C. Binge, and A. Sriratana Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer Cancer Res 73 2013 5066 5079
19. P.R. Brakeman, A.A. Lanahan, R. O'Brien, K. Roche, C.A. Barnes, and R.L. Huganir Homer: a protein that selectively binds metabotropic glutamate receptors Nature 386 1997 284 288
20. S. Pellegrin, and H. Mellor The Rho family GTPase Rif induces filopodia through mDia2 Curr Biol 15 2005 129 133
21. A. Ignatov, T. Ignatov, A. Roessner, S.D. Costa, and T. Kalinski Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells Breast Cancer Res Treat 123 2010 87 96
22. A. Ignatov, T. Ignatov, and C. Weissenborn G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer Breast Cancer Res Treat 128 2011 457 466
23. L.J. Schedlich, V.M. Yenson, and R.C. Baxter TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells Mol Cell Endocrinol 377 2013 56 64
24. D. Accili, and K.C. Arden FoxOs at the crossroads of cellular metabolism, differentiation, and transformation Cell 117 2004 421 426
25. Y.C. Lim, L. Li, and Z. Desta Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells J Pharmacol Exp Ther 318 2006 503 512
26. C. Davies, J. Godwin, and R. Gray Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 2011 771 784
27. C. Davies, H. Pan, and J. Godwin Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Lancet 381 2013 805 816
28. M.M. Gottardis, and V.C. Jordan Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration Cancer Res 48 1988 5183 5187
29. M.M. Gottardis, R.J. Wagner, E.C. Borden, and V.C. Jordan Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro Cancer Res 49 1989 4765 4769
30. M.M. Gottardis, S.Y. Jiang, M.H. Jeng, and V.C. Jordan Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens Cancer Res 49 1989 4090 4093
31. E.S. Lee, J.M. Schafer, and K. Yao Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice Clin Cancer Res 6 2000 4893 4899
32. J. Frasor, E.C. Chang, and B. Komm Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome Cancer Res 66 2006 7334 7340
33. J. Frasor, J.M. Danes, B. Komm, K.C. Chang, C.R. Lyttle, and B.S. Katzenellenbogen Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype Endocrinology 144 2003 4562 4574
34. J. Frasor, F. Stossi, J.M. Danes, B. Komm, C.R. Lyttle, and B.S. Katzenellenbogen Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res 64 2004 1522 1533
35. L.C. Hodges, J.D. Cook, and E.K. Lobenhofer Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells Mol Cancer Res 1 2003 300 311
36. E.V. Jensen, and V.C. Jordan The estrogen receptor: a model for molecular medicine Clin Cancer Res 9 2003 1980 1989
37. S. Benjamin, H. Weidberg, and D. Rapaport EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity Biochem J 439 2011 433 442
38. J.J. Blume, A. Halbach, D. Behrendt, M. Paulsson, and M. Plomann EHD proteins are associated with tubular and vesicular compartments and interact with specific phospholipids Exp Cell Res 313 2007 219 231
39. L.C. Simone, S. Caplan, and N. Naslavsky Role of phosphatidylinositol 4,5-bisphosphate in regulating EHD2 plasma membrane localization PLoS One 8 2013 e74519
40. R. Rotem-Yehudar, E. Galperin, and M. Horowitz Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29 J Biol Chem 276 2001 33054 33060
41. J. Dahan, Y. Nouët, and G. Jouvion LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis Mol Cell Biol 33 2013 3299 3308
42. G. Yatherajam, P.P. Banerjee, and K.A. McCorkell Cutting edge: association with I kappa B kinase beta regulates the subcellular localization of Homer3 J Immunol 185 2010 2665 2669
43. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657